Boston Scientific company profile
Company profile
Boston Scientific has 59,000 employees and is headquartered in Marlborough, United States.
Boston Scientific organizes its medical devices into two segments, MedSurg and Cardiovascular, serving interventional specialties worldwide. The MedSurg range includes gastrointestinal tools such as biliary stent systems and SpyGlass single-use scopes, urological products such as ureteral stents and holmium laser systems, and spinal cord stimulators and deep brain stimulation systems for movement disorders and chronic pain. The Cardiovascular segment offers the WATCHMAN FLX left atrial appendage closure device, cardioverter and cardiac resynchronization therapy defibrillators, pacemakers, insertable cardiac monitors, and devices for peripheral vascular disease and certain cancers. By region, the United States accounts for 64.1% of revenue, followed by EMEA at 17.2% and Asia Pacific at 15.3%.
In the fiscal year ended December 2025, revenue reached 20.1 billion US dollars, up 19.9% from the previous year, and net income came to 2.9 billion US dollars. The company had 59,000 employees and is headquartered in Marlborough, Massachusetts, where it was incorporated in 1979.
Company facts
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Headquarters
- 300 Boston Scientific Way, 01752-1234, Marlborough
- Employees
- 59,000
- Chief executive
- Michael Mahoney
- Founded
- 1979
- Fiscal year
- January - December
- Listing
- BSX · NYSE
- Indices
- S&P 500
- Currency
- USD
- ISIN
- US1011371077
- Website
- bostonscientific.com
Boston Scientific and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| Boston ScientificBSX | United States | $63.33B | 59,000 | 19.6% | 18.4 |
| Edwards LifesciencesEW | United States | $61.59B | 16,000 | 28.8% | 61.6 |
| GE HealthCare TechnologiesGEHC | United States | $37B | 54,000 | 13.8% | 17.3 |
| StrykerSYK | United States | $118.29B | 56,000 | 24.0% | 33.1 |
| MedtronicMDT | United States | $130.88B | 95,000 | 20.1% | 25.1 |
| DexComDXCM | United States | $30.44B | 11,000 | 24.0% | 32.1 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
